Project Grant K01AR086353
- Federal Grant Award Summary The University of Colorado received a $348,339 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), with performance occurring in Boulder, Colorado. The award period runs from May 1, 2026, through April 30, 2028. The research project investigates the mechanical role of hyaluronic acid (HA), a glycosaminoglycan component, in...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded $382,537 to The Regents of the University of Colorado-Denver on August 1, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) for a five-year research project extending through July 31, 2030. The primary deliverable is basic and translational research investigating the pathogenic roles of Granzyme K-expressing CD8 T cells in...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $636,198 Project Grant to the University of Miami on September 15, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The research project, titled "Deciphering Disc Degeneration: Untangling the Roles of Age and Inflammation," focuses on identifying factors that diminish proteoglycan (PG) anabolism and contribute to...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $320,417 Project Grant to The Regents of the University of Colorado (University of Colorado-Denver) on August 15, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award supports a five-year research initiative through July 31, 2030, focused on deciphering complement-dependent macrophage phenotypes in rheumatoid arthritis...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded the University of Delaware a $666,825 Project Grant on September 1, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to investigate the structural and functional roles of muscle-subtendon units in Achilles tendinopathy. The research will extend through June 30, 2030, utilizing advanced biomechanical sensors, magnetic resonance imaging...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded New Jersey Institute of Technology a $330,107 Project Grant effective September 1, 2025, through June 30, 2030, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This award supports fundamental research investigating the role of stress anisotropy—directional stress differences in extracellular matrices—in fibroblast activation and its...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $540,974 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), awarded September 19, 2025, with completion targeted for August 31, 2030. The award funds mechanistic research into Janus kinase (JAK) signaling pathways in post-traumatic osteoarthritis (PTOA), specifically...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $172,034 Project Grant to the University of Nebraska Medical Center on August 15, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This research initiative, with a completion date of June 30, 2030, focuses on identifying molecular and epidemiologic determinants of myocardial dysfunction and heart failure (HF) in patients with...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded The Regents of the University of California, San Francisco a $219,609 Project Grant effective September 5, 2025, through August 31, 2027, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This exploratory/developmental research project delivers a novel in vitro methodology to assess mechanical failure of bone matrix using micropillar...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $636,479 Project Grant to The Trustees of Columbia University in the City of New York (Health Sciences Division) to conduct fundamental and translational research on the role of macrophages in intervertebral disc (IVD) degeneration and discogenic back pain. The project, which commenced May 1, 2026 and will conclude January 31, 2031, aims to elucidate the mechanisms by which...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a Project Grant totaling $124,158 to The Regents of the University of Colorado–Denver to conduct research investigating the biomechanical mechanisms underlying chronic joint pain in individuals with generalized joint hypermobility (GJH). The research, initiated May 15, 2026, and scheduled for completion March 31, 2031, examines how dynamic joint stability—comprising passive (connective tissue), active (muscle), and neural (sensorimotor control) subsystems—contributes to pain development in symptomatic GJH populations. The study aims to characterize performance across all three stability subsystems of the neck and determine the role of central sensitization in chronic pain manifestation, with particular focus on understanding why some individuals with GJH remain asymptomatic while others develop chronic pain conditions. This research supports the NIAMS Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) by addressing a significant gap in mechanistic understanding of musculoskeletal pain pathophysiology. The anticipated deliverables include empirical data on biomechanical and neurophysiological factors in GJH populations, research findings to inform evidence-based clinical management guidelines, and peer-reviewed publications advancing the scientific knowledge of joint hypermobility-related pain mechanisms. The work is being performed at the University of Colorado–Denver facility in Aurora, Colorado.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $124.2k | 5/14/26 |